Nami Surgical secures £3.4m for robotic surgery technology
Glasgow-based medical technology company Nami Surgical has secured £3.4 million in additional funding to develop and commercialise its ultrasonic technology for robotic-assisted surgery.
The investment includes £2 million from the Scottish National Investment Bank, alongside backing from existing investors Eos Advisory, Scottish Enterprise, and the Investment Fund for Scotland, managed by Maven Capital Partners.
Funding to create five jobs
The funding will support Nami Surgical’s commercialisation plans and expansion of its research and development team.
The company expects to create five additional jobs at its headquarters in Hillington, on the outskirts of Glasgow. The announcement follows a £1.9 million investment round completed earlier in 2026, when Nikki Palfrey was appointed chief executive.
How Nami Surgical’s technology works
Nami Surgical has developed a miniaturised ultrasonic scalpel designed for use in robotic-assisted surgery.
Ultrasonic scalpels use high-frequency vibrations to cut tissue and seal blood vessels during surgical procedures. Traditional designs have been too large and rigid to integrate effectively with the jointed instruments used in surgical robots.
Nami’s technology reduces the size of the transducer, the component responsible for generating ultrasonic vibrations. According to the company, this allows the scalpel to bend and rotate within robotic surgical instruments while retaining its cutting and sealing functions.
The company is developing the patent-protected technology for commercial use and seeking partnerships with international medical device manufacturers.
University of Glasgow spin-out
Nami Surgical was founded in 2021 by Dr Nico Fenu and Dr Rebecca Cleary as a University of Glasgow spin-out.
Fenu is now chief operating officer, while Palfrey took over as chief executive in January 2026.
The company has secured ISO 13485 certification, a quality management standard for medical devices, and was named Bio-tech Manufacturer of the Year at the 2026 Made in Scotland Awards.
Palfrey said the company’s ambition was to “establish Nami as a key technology partner in the global robotic surgery market”.
Related Scottish business news
